Biomerica (BMRA) Enterprise Value (2010 - 2026)

Biomerica has disclosed Enterprise Value across 17 years of filings, most recently posting -$1.3 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$1.3 million, up 56.31% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.3 million (up 56.31% YoY), and the FY2025 annual result was -$3.1 million, up 26.67% from the prior year.
• Enterprise Value came in at -$1.3 million for Q1 2026 at Biomerica, up from -$2.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.3 million in Q1 2026 to a low of -$10.2 million in Q1 2022.
• The 5-year median for Enterprise Value is -$4.2 million (2024), against an average of -$4.9 million.
• Across the five-year window, Enterprise Value plunged 92.96% in 2022 and soared 67.12% in 2023, its largest moves.
• Biomerica's Enterprise Value stood at -$5.1 million in 2022, then slumped by 40.81% to -$7.1 million in 2023, then soared by 66.75% to -$2.4 million in 2024, then dropped by 7.21% to -$2.5 million in 2025, then jumped by 47.46% to -$1.3 million in 2026.
• The last three Enterprise Value figures came in at -$1.3 million (Q1 2026), -$2.5 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.